[PDF][PDF] Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
SJ Cohen, CJ Punt, N Iannotti, BH Saidman… - 2008 - researchgate.net
SJ Cohen, CJ Punt, N Iannotti, BH Saidman, KD Sabbath, NY Gabrail, J Picus, M Morse…
2008•researchgate.netRelationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and
Overall Survival in Patients With Meta Page 1 Relationship of Circulating Tumor Cells to Tumor
Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic
Colorectal Cancer Steven J. Cohen, Cornelis JA Punt, Nicholas Iannotti, Bruce H. Saidman, Kert
D. Sabbath, Nashat Y. Gabrail, Joel Picus, Michael Morse, Edith Mitchell, M. Craig Miller, Gerald
V. Doyle, Henk Tissing, Leon WMM Terstappen, and Neal J. Meropol From the Fox Chase …
Overall Survival in Patients With Meta Page 1 Relationship of Circulating Tumor Cells to Tumor
Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic
Colorectal Cancer Steven J. Cohen, Cornelis JA Punt, Nicholas Iannotti, Bruce H. Saidman, Kert
D. Sabbath, Nashat Y. Gabrail, Joel Picus, Michael Morse, Edith Mitchell, M. Craig Miller, Gerald
V. Doyle, Henk Tissing, Leon WMM Terstappen, and Neal J. Meropol From the Fox Chase …
Purpose
As treatment options expand for metastatic colorectal cancer (mCRC), a blood marker with a prognostic and predictive role could guide treatment. We tested the hypothesis that circulating tumor cells (CTCs) could predict clinical outcome in patients with mCRC.
researchgate.net